Wealthedge Investment Advisors, LLC Bristol Myers Squibb CO Transaction History
Wealthedge Investment Advisors, LLC
- $264 Billion
- Q3 2025
A detailed history of Wealthedge Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wealthedge Investment Advisors, LLC holds 112,152 shares of BMY stock, worth $5.25 Million. This represents 1.91% of its overall portfolio holdings.
Number of Shares
112,152
Previous 96,686
16.0%
Holding current value
$5.25 Million
Previous $4.48 Billion
13.01%
% of portfolio
1.91%
Previous 1.86%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,682Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...